** Shares of telehealth platform Hims & Hers Health HIMS.N fall 1.8% to $54.54
** The U.S. FDA Commissioner Martin Makary said late on Friday that HIMS' Super Bowl advertisement breached federal law as it highlighted the benefits of weight-loss drugs without mentioning side effects
** Under federal law, advertisements for prescription drugs must present a "fair balance" of risks and benefits, Makary said in a peer-reviewed medical journal published by the American Medical Association
** The company's "Super Bowl ad did not advertise any one treatment or solution," Hims & Hers spokesperson says
** Including session moves, stock up 126.32% YTD